Price
Financials
Standalone, Rs crore| Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 16.23 | 12.85 | 4.97 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 19.37 | 17.71 | 10.90 | 2.27 | 1.95 | 1.95 | 1.71 | 1.71 | 1.71 | 1.71 | 0.44 | 0.84 |
| Operating Profit | -3.14 | -4.86 | -5.93 | -2.01 | -1.95 | -1.95 | -1.71 | -1.71 | -1.71 | -1.71 | -0.44 | -0.84 |
| OPM % | -19.35% | -37.82% | -119.32% | -773.08% | ||||||||
| Other Income | 0.02 | 0.13 | 0.66 | 0.01 | -1.88 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.23 |
| Interest | 2.09 | 1.26 | 2.70 | 0.05 | -0.54 | 0.16 | 0.17 | 0.17 | 0.17 | 0.17 | 0.46 | 0.34 |
| Depreciation | 8.59 | 5.73 | 5.67 | 5.14 | 5.97 | 5.56 | 5.34 | 5.34 | 5.34 | 5.34 | 4.85 | 5.10 |
| Profit before tax | -13.80 | -11.72 | -13.64 | -7.19 | -9.26 | -7.66 | -7.22 | -7.22 | -7.22 | -7.22 | -5.48 | -6.05 |
| Tax % | 3.41% | -10.24% | 5.21% | -1.39% | 1.84% | -2.22% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -14.27 | -10.52 | -14.35 | -7.09 | -9.43 | -7.49 | -7.22 | -7.22 | -7.22 | -7.22 | -5.48 | -6.05 |
| EPS in Rs | -2.31 | -1.70 | -2.32 | -1.15 | -1.52 | -1.21 | -1.17 | -1.17 | -1.17 | -1.17 | -0.89 | -0.98 |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 513 | 617 | 919 | 763 | 438 | 231 | 75 | 73 | 71 | 18 | 0 | 0 |
| Expenses | 430 | 515 | 762 | 836 | 519 | 310 | 381 | 118 | 87 | 33 | 6 | 5 |
| Operating Profit | 83 | 102 | 157 | -73 | -82 | -78 | -306 | -46 | -15 | -15 | -6 | -5 |
| OPM % | 16% | 17% | 17% | -10% | -19% | -34% | -410% | -62% | -22% | -82% | ||
| Other Income | 5 | 15 | 4 | 6 | 13 | 1 | 0 | 4 | 4 | -1 | 0 | 0 |
| Interest | 38 | 41 | 64 | 73 | 83 | 99 | 108 | 10 | 9 | 3 | 1 | 1 |
| Depreciation | 6 | 8 | 31 | 55 | 68 | 73 | 67 | 53 | 35 | 23 | 22 | 21 |
| Profit before tax | 44 | 69 | 66 | -195 | -220 | -249 | -481 | -105 | -55 | -42 | -29 | -26 |
| Tax % | 22% | 23% | 23% | -28% | -40% | 52% | 1% | 3% | 3% | -1% | 0% | |
| Net Profit | 34 | 53 | 51 | -140 | -132 | -379 | -485 | -108 | -57 | -41 | -29 | -26 |
| EPS in Rs | 8.54 | 8.27 | -22.58 | -21.28 | -61.29 | -78.39 | -17.46 | -9.21 | -6.69 | -4.63 | -4.21 | |
| Dividend Payout % | 0% | 6% | 3% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | -100% | ||
| Compounded Profit Growth | % | 14% | 20% | 12% | ||
| Stock Price CAGR | 0% | % | % | % | ||
| Return on Equity | % | % | % | % |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 37 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 |
| Reserves | 121 | 317 | 367 | 239 | 121 | -258 | -743 | -851 | -908 | -949 | -977 | -990 |
| Borrowings | 421 | 474 | 555 | 777 | 842 | 957 | 972 | 979 | 984 | 985 | 157 | 158 |
| Other Liabilities | 111 | 214 | 331 | 161 | 202 | 189 | 287 | 303 | 281 | 275 | 1,108 | 1,109 |
| Total Liabilities | 690 | 1,067 | 1,314 | 1,239 | 1,227 | 950 | 577 | 493 | 419 | 372 | 349 | 339 |
| Fixed Assets | 130 | 163 | 188 | 334 | 331 | 395 | 371 | 349 | 326 | 298 | 278 | 267 |
| CWIP | 41 | 112 | 187 | 72 | 81 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Investments | 2 | 6 | 4 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Other Assets | 517 | 786 | 936 | 827 | 809 | 542 | 193 | 132 | 80 | 62 | 59 | 59 |
| Total Assets | 690 | 1,067 | 1,314 | 1,239 | 1,227 | 950 | 577 | 493 | 419 | 372 | 349 | 339 |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -40 | -31 | 3 | 207 | -111 | 28 | -4 | 90 | 2 | 3 | ||
| Cash from Investing Activity | -56 | -87 | -180 | -205 | -108 | -30 | -16 | 1 | 0 | 1 | ||
| Cash from Financing Activity | 103 | 122 | 186 | 7 | 197 | -4 | 17 | -93 | -2 | -4 | ||
| Net Cash Flow | 6 | 4 | 8 | 9 | -23 | -6 | -3 | -2 | -0 | 0 | ||
| Free Cash Flow | -87 | -91 | -110 | 97 | -158 | 3 | -17 | 91 | 2 | 4 | ||
| CFO/OP | -67% | -28% | 17% | 140% | 151% | -1% | 5% | -29% | -4% | -20% |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 135 | 137 | 163 | 88 | 66 | 124 | 155 | 342 | 335 | 148 | 562 | |
| Inventory Days | 234 | 239 | 276 | 237 | 167 | 363 | 450 | 45 | 61 | 91 | 12 | |
| Days Payable | 123 | 82 | 137 | 149 | 59 | 187 | 146 | 104 | 420 | 465 | 1,325 | |
| Cash Conversion Cycle | 246 | 294 | 302 | 176 | 174 | 301 | 460 | 283 | -24 | -226 | -751 | |
| Working Capital Days | 225 | 255 | 50 | 5 | 36 | 45 | -169 | -1,708 | -1,483 | -1,620 | -6,735 | |
| ROCE % | 19% | 17% | 15% | 14% | -12% | -13% | -17% | -71% | -39% | -28% | -31% |
| Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% | 37.79% |
| FIIs | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% | 8.06% |
| DIIs | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.59% | 0.58% | 0.58% | 0.58% | 0.58% |
| Public | 53.57% | 53.57% | 53.57% | 53.57% | 53.57% | 53.57% | 53.57% | 53.56% | 53.57% | 53.57% | 53.57% | 53.57% |
| No. of Shareholders | 13,132 | 13,095 | 13,044 | 12,959 | 12,899 | 12,824 | 12,794 | 12,867 | 12,885 | 13,226 | 13,360 | 13,652 |
Fundamentals
Market Cap₹ 34.0 Cr.
Current Price₹ 5.50
Book Value₹ -150
ROCE%
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-100%
Compounded Profit Growth (TTM)12%
Standalone figures.
Valuation
P/B, 3-year average-0.05x
P/B, 5-year average-0.06x
Profitability
ROE3.18%
ROA-7.94%
ROE, 3-year average4.98%
ROCE, 3-year average-30.31%
ROA, 3-year average-10.30%
ROE, 5-year average28.05%
ROCE, 5-year average-42.77%
ROA, 5-year average-22.93%
Other income / net worth-0.00%
Per share
EPS (TTM)Rs -4.20
EPS (latest quarter)Rs -0.98
EPS, 3-year averageRs -9.21
EPS, 5-year averageRs -35.02
Book value per shareRs -147.84
Free cash flow per shareRs 0.65
Efficiency
Inventory turnover0.00x
Creditor days1325 days
Cash conversion cycle-751 days
Working capital days-6735 days
Leverage
Total debtRs 157 Cr
Cash and bankRs 1 Cr
Net debtRs 156 Cr
Debt to equity-0.17x
Interest coverage-21.78x
Owners' fund to total sources-261.84%
Debt to assets44.83%
Cash flow
Free cash flow (latest year)Rs 4 Cr
FCFE (approx.: FCF + change in debt)Rs -824 Cr
Statement figures
Operating profit (latest quarter)Rs -1 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -4 Cr
PBDT (TTM)Rs -5 Cr
Profit before tax (TTM)Rs -26 Cr
Net profit (TTM)Rs -26 Cr
Net profit (latest year)Rs -29 Cr
Net profit (latest quarter)Rs -6 Cr
Depreciation (TTM)Rs 21 Cr
Depreciation (latest quarter)Rs 5 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 62 Cr
ReservesRs -977 Cr
Shareholders' fundsRs -915 Cr
Total assetsRs 349 Cr
Net blockRs 278 Cr
Capital work in progressRs 7 Cr
InvestmentsRs 6 Cr
ReceivablesRs 27 Cr
InventoryRs 1 Cr
Other liabilitiesRs 1,108 Cr
Shares outstanding (crore)6.19
Ownership
Promoter holding37.79% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
| serious | Negative equity Shareholders' equity is negative |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Dec 2020Sales ₹0 Cr.
Net loss ₹6 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Parabolic Drugs Ltd?
Parabolic Drugs Ltd (533211) has a market capitalisation of Rs 34.0 Cr. at the close.
What were Parabolic Drugs Ltd's latest quarterly results?
In the Dec 2020 quarter, Parabolic Drugs Ltd sales was Rs 0 Cr with a net loss of Rs 6 Cr.